Genelux (GNLX) Non-Current Assets (2022 - 2026)

Genelux (GNLX) recorded quarterly Non-Current Assets of $5.6 million in Q1 2026, up 44.16% quarter-over-quarter from $3.9 million in Q4 2025.

Genelux (GNLX) Non-Current Assets (2022 - 2026) Analysis & Trends

Genelux's Non-Current Assets history runs 5 years deep, the most recent figure standing at $5.6 million for Q1 2026.

  • In Q1 2026, Non-Current Assets changed N/A year-over-year to $5.6 million; the TTM figure through Sep 2025 stood at $3.4 million (down 20.17% YoY), while the FY2025 annual figure was $3.9 million, up 23.01% from the prior year.
  • Non-Current Assets was $5.6 million for Q1 2026 at Genelux, up from $3.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $10.3 million in Q2 2024 to a low of $2.9 million in Q3 2023.
  • Historically, Non-Current Assets has averaged $4.3 million across 5 years, with a median of $3.6 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Assets surged 48.74% in 2024, then slumped 70.78% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $3.6 million in 2022, then advanced by 1.4% to $3.7 million in 2023, then decreased by 14.15% to $3.2 million in 2024, then increased by 23.01% to $3.9 million in 2025, then surged by 44.16% to $5.6 million in 2026.
  • The last three Non-Current Assets figures came in at $5.6 million (Q1 2026), $3.9 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Genelux 129.36 Mn 129.36 Mn - 5.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.62 Mn
Dec 31, 2025 3.90 Mn
Sep 30, 2025 3.44 Mn
Jun 30, 2025 3.01 Mn
Dec 31, 2024 3.17 Mn
Sep 30, 2024 4.30 Mn
Jun 30, 2024 10.31 Mn
Mar 31, 2024 3.47 Mn
Dec 31, 2023 3.69 Mn
Sep 30, 2023 2.89 Mn
Dec 31, 2022 3.64 Mn